. Author manuscript; available in PMC: 2011 Apr 1.

Published in final edited form as: Cancer Res. 2010 Sep 14;70(19):7392–7399. doi: 10.1158/0008-5472.CAN-10-2027

Table 4.

Concentrations of resveratrol and its major metabolites in the plasma of patients who received resveratrol daily for 8 days at 0.5 or 1.0g

	Plasma Levels (nmol/mL)^*
Species	0.5g	1.0g
Resveratrol	loq^**	loq
Resveratrol-3-O-glucuronide	loq	0.24±0.13 (0.07-0.50)
Resveratrol-4′-O-glucuronide	0.04±0.06 (0-0.16)	0.24±0.17 (0.05-0.57)
Resveratrol sulfate glucuronide	13.4±16.5 (0-34.9)	22.3±10.1 (6.67-36.3)
Resveratrol disulfate	0.31±0.20 (0-0.59)	0.60±0.81 (0.17-2.86)
Resveratrol-3-O-sulfate	0.13±0.15 (0-0.52)	0.59±0.41 (0.17-1.33)
Resveratrol- 4′-O-sulfate	loq	loq

Values are the mean±SD of 10 patients per dose (and range).

^**

loq=close to or below the limit of quantitation.